Emyria Limited has disclosed a Change of Director’s Interest Notice regarding Dr. Michael Winlo's holdings of securities. As of April 4, 2025, Dr. Winlo holds 1,115,897 fully paid ordinary shares and various unlisted options. The change in holdings involved acquiring 69,378 fully paid ordinary shares through an on-market trade at $0.027 per share. No securities were disposed of in this transaction. Dr. Winlo remains a trustee and beneficiary of the account holding additional unlisted options exercisable at different prices and dates.

This update provides transparency regarding the director's interests in the company and demonstrates ongoing alignment with Emyria's objectives. Investors are encouraged to review this information and may direct any questions they have regarding the announcement to Emyria for further clarification or insights.